Rivaroxaban, (R)- is a pharmaceutical compound that functions as a direct factor Xa inhibitor. It is used as an active pharmaceutical ingredient in the manufacturing of anticoagulant medications.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing Rivaroxaban, (R)-?
Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.
Acenocoumarol
pharmaceutical raw material
Apixaban
pharmaceutical raw material
(RS)-warfarin
pharmaceutical raw material
Phenindione
pharmaceutical raw material
(R)-2-((6-(3-Aminopiperidin-1-yl)-2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)methyl)benzonitrile
pharmaceutical raw material
Trelagliptin
pharmaceutical raw material
2-((6-(3-Amino-1-piperidinyl)-3,4-dihydro-3-methyl-2,4-dioxo-1(2H)-pyrimidinyl)methyl)benzonitrile
pharmaceutical raw material
Cupric citrate
pharmaceutical raw material
5-chloro-N-[[(5R)-2-oxo-3-[4-(3-oxomorpholin-4-yl)phenyl]-1,3-oxazolidin-5-yl]methyl]thiophene-2-carboxamide
KGFYHTZWPPHNLQ-CQSZACIVSA-N
C1COCC(=O)N1C2=CC=C(C=C2)N3C[C@H](OC3=O)CNC(=O)C4=CC=C(S4)Cl
Sourcing Rivaroxaban, (R)-?
Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.